Lets say drug X and drug Y possess the same active ingredient and dose...So my Q is, can all the brand names in the market be used as alternatives to each other with no worries of bioavailability ? or Brand names didn't undergo bioequivalence studies ?
Everything depends on class of biopharmaceutical classification of active subtances. as a rule , substances of 2 and 4 classes undergo these studies. Secondly, guide on bioequivalence studies regulate studies for alternatives. How I remember the highest dose u der
What class 2 and 4 ? And does this apply to all countries ? or your speaking in terms of the United States ?
Dr.Nataliia, if they did undergo bioequivalence studies before being into the market, what is the need for this study ?Article Post Marketing Bioequivalence Study of Six Brands of Ciprofl...
- Badges
- Science topic
- Similar topics
- Mathematical Sciences
- Statistics
- Statistical Software
- SPSS